Abstract
Spinocerebellar ataxia type 1 (SCA1) is one of nine inherited, typically adult onset, polyglutamine neurodegenerative diseases. To examine whether development impacts SCA1, we used a conditional transgenic mouse model of SCA1 to delay the postnatal expression of mutant ATXN1 until after completion of cerebellar development. Delayed postnatal expression of mutant ATXN1 led to a substantial reduction in severity of disease in adults in comparison with early postnatal gene expression. This was linked to a destabilization of RORα, a transcription factor critical for cerebellar development. In SCA1 mice, there was a depletion of RORα and a reduction in expression of genes controlled by RORα. Partial loss of RORα enhanced mutant ATXN1 pathogenicity. Additionally, evidence points to the existence of a complex containing ATXN1, RORα, and the RORα coactivator Tip60. These studies indicate RORα and Tip60 have a role in SCA1 and suggest a mechanism by which compromising cerebellar development contributes to severity of neurodegeneration in an adult. © 2006 Elsevier Inc. All rights reserved.
Cite
CITATION STYLE
Serra, H. G., Duvick, L., Zu, T., Carlson, K., Stevens, S., Jorgensen, N., … Orr, H. T. (2006). RORα-Mediated Purkinje Cell Development Determines Disease Severity in Adult SCA1 Mice. Cell, 127(4), 697–708. https://doi.org/10.1016/j.cell.2006.09.036
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.